6L1Y image
Entry Detail
PDB ID:
6L1Y
Keywords:
Title:
structure of gp120/CD4 with a non-canonical surface
Biological Source:
PDB Version:
Deposition Date:
2019-10-01
Release Date:
2020-05-20
Method Details:
Experimental Method:
Resolution:
2.47 Å
R-Value Free:
0.25
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:gp120
Chain IDs:A
Chain Length:392
Number of Molecules:1
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Description:T-cell surface glycoprotein CD4
Chain IDs:B (auth: C)
Chain Length:177
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
A non-canonical binding interface in the crystal structure of HIV-1 gp120 core in complex with CD4.
Sci Rep 7 46733 46733 (2017)
PMID: 28429756 DOI: 10.1038/srep46733

Abstact

Numerous crystal structures of HIV gp120 have been reported, alone or with receptor CD4 and cognate antibodies; however, no sole gp120/CD4 complex without stabilization by an antibody is available. Here, we report a crystal structure of the gp120/CD4 complex without the aid of an antibody from HIV-1 CRF07_BC, a strain circulating in China. Interestingly, in addition to the canonical binding surface, a second interacting interface was identified. A mutagenesis study on critical residues revealed that the stability of this interface is important for the efficiency of Env-mediated membrane fusion. Furthermore, we found that a broad neutralizing antibody, ibalizumab, which targets CD4 in the absence of gp120, occupies the same binding surface as the second interface identified here on gp120. Therefore, we identified the possibility of the involvement of a second gp120-CD4 interaction interface during viral entry, and also provided a reasonable explanation for the broad activity of neutralizing antibody ibalizumab.

Legend

Protein

Chemical

Disease

Primary Citation of related structures